FDA Says that Drug Makers Must Stop Ranitidine Sales
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) told drug makers who sell ranitidine-based medications to stop. Ranitidine is the generic name for the active ingredient in acid-reducing drugs like Zantac. Zantac is known as the most-prescribed drug across the globe in 1987, according to Wired. Now the FDA has asked … [Read more...] about FDA Says that Drug Makers Must Stop Ranitidine Sales
Zantac Still Being Sold in US
USA- dailymail.co.uk writes that while other countries are removing Zantac from their drug stores, the heartburn medication can still be found in pharmacies in the United States. In Europe, four prescription varieties of the drug were subject to recalls. The generic variety, as well as the brand name versions of the drug, were found … [Read more...] about Zantac Still Being Sold in US
Generic Zantac Cancer
WASHINGTON, D.C. — The U.S. Food and Drug Administration will work with drug manufacturing companies to recall generic versions of Zantac because of the presence of a potentially cancer-causing agent located in the medication. The U.S. FDA said that potentially cancer-causing agent in Zantac is n-nitrosodimethylamine or NDMA for … [Read more...] about Generic Zantac Cancer
FDA Warns of Carcinogen Lurking in Zantac
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) released a statement discussing the potential dangers users of ranitidine medications face. Ranitidine, the generic version of the anti-heartburn medication Zantac, may contain a potentially carcinogenic chemical according to the latest statement announced by the FDA. The … [Read more...] about FDA Warns of Carcinogen Lurking in Zantac
